Hemodynamics During the Soccer Championship 2012

Myocardial Infarction Clinical Trial

Official title:

Central Hemodynamics, Arterial Stiffness, Heartrate and Endothelial Dysfunktion During the European Soccer Championship 2012

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01617863
• Other study ID #: HL-Med2-EM-2012
• Status: Completed
• Phase: N/A
• First received: June 8, 2012
• Last updated: July 2, 2012
• Start date: June 2012
• Est. completion date: July 2012

Study information

• Verified date: June 2012
• Source: University of Schleswig-Holstein
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Federal Institute for Drugs and Medical Devices
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine in soccer fans whether and to which extend positive or negative emotions during the European soccer Championship affects Central Hemodynamics, Arterial Stiffness, Heartrate and Endothelial Dysfunktion.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 180
• Est. completion date: July 2012
• Est. primary completion date: July 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Best fit:

• cardiomyopathy "severe myocardial disease leading to heart failure"

• Angina, stable for at least 7 days

• Myocardial infarction during 4 weeks before inclusion, actually stable condition

• Angina, Stable, CCS II-IV

Exclusion Criteria:

• not interested in soccer championship

• age <18y

• dementia

• atrial tachycardia

• drug/alcohol abuse

• chronic kidney disease, stage 5

• pulmonary/tricuspid valve insufficiency/stenoses

• non compliant

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Angina, Stable
• Angina, Unstable
• Cardiomyopathies
• Myocardial Infarction
• Severe Cardiomyopathy

Locations

Country	Name	City	State
Germany	Universitätsklinikum Erlangen	Erlangen	Bayern
Germany	Universitätsklinikum Greifswald	Greifswald	Mecklenburg-Vorpommern
Germany	Universitätsklinikum Eppendorf	Hamburg
Germany	UKSH-Lübeck	Lübeck	Schleswig-Holstein

Sponsors (5)

Lead Sponsor	Collaborator
University of Schleswig-Holstein	UKSH Campus Kiel, Kiel, Germany, Universitätsklinikum Eppendedorf, Hamburg, Germany, Universitätsklinikum Erlangen, Erlangen, Bayern, Germany, Universitätsklinikum Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany

Country where clinical trial is conducted

Germany,